Aclaris Therapeutics (ACRS) stock forecast for 2022 – 2027

Are you interested in Aclaris Therapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ACRS stock price in 2022-2027. Is ACRS a good long term stock? When should I take profit in Aclaris Therapeutics stock? Buy or sell stock? Will ACRS stock price go up? What are analysts’ forecasts for ACRS stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. ACRS stock returns are also predicted based on historical data.

According to our research, ACRS stock is a awesome long-term investment. ACRS share price has been in a bull cycle for the past year. Aclaris Therapeutics, Inc. stock trend is positive.

Aclaris Therapeutics company info

Industry Biotechnology
Address 640 Lee Road, Wayne, PA, 19087, United States
Website https://www.aclaristx.com

Forecasting

52 Week High: 19.9 USD
52 Week Low: 10.6807 USD
1 Year Forecast: 20.0971 USD
5 Year Forecast: 57.8734 USD

Agilent Technologies info

Market Cap: 668.3M
52 Week Change: -10.0997%
52 Week High: 30.38 USD
52 Week Low: 9.26 USD
Beta: 1.05247
50 Day Moving Average: 12.67
90 Day Moving Average: 13.258
200 Day Moving Average: 14.92
Resistance Level: 11.7116
Pivot Point: 10.8807
Support Level: 10.207
Enterprise Value: 440,097,440
Forward P/E: -6.21
Forward EPS: -1.67
Profit Margin: 0.00%
Shares Outstanding: 61,227,300
EBITDA: -7.62
Held Percent Institutions: 97.85%
PEG Ratio (5Y): -0.08
Trailing EPS: -1.55

Aclaris Therapeutics stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Aclaris Therapeutics Stock Forecast for 2022

March 2022 11.88 12.12 2.02%
April 2022 12.74 14.14 10.99%
May 2022 12.87 13.13 2.02%
June 2022 12.74 13 2.04%
July 2022 13.13 14 6.63%
August 2022 14.14 14.28 0.99%
September 2022 13.86 16 15.44%
October 2022 16.16 15.15 -6.25%
November 2022 14.7 16.16 9.93%
December 2022 15.84 17.82 12.5%

Aclaris Therapeutics Stock Forecast for 2023

January 2023 18.18 20.79 14.36%
February 2023 20.79 22.44 7.94%
March 2023 21.56 23 6.68%
April 2023 23 23.52 2.26%
May 2023 22.77 22.77 0%
June 2023 23 23 0%
July 2023 24.48 24.48 0%
August 2023 24 23.76 -1%
September 2023 23.52 26 10.54%
October 2023 25.74 25 -2.87%
November 2023 25.25 25.74 1.94%
December 2023 26.26 28.42 8.23%

Aclaris Therapeutics Stock Forecast for 2024

January 2024 28 31 10.71%
February 2024 31 32 3.23%
March 2024 31.36 32.32 3.06%
April 2024 33.66 34.68 3.03%
May 2024 33.66 32.34 -3.92%
June 2024 33.66 33 -1.96%
July 2024 33.66 33.66 0%
August 2024 34 34.34 1%
September 2024 34.3 35.28 2.86%
October 2024 36.72 35.7 -2.78%
November 2024 35.35 35.64 0.82%
December 2024 37.74 37.24 -1.32%

Aclaris Therapeutics Stock Forecast for 2025

January 2025 37.62 40.59 7.89%
February 2025 41.82 42.42 1.43%
March 2025 41.16 42.57 3.43%
April 2025 43.43 44.88 3.34%
May 2025 42.57 43 1.01%
June 2025 42.57 43.12 1.29%
July 2025 43.56 43.12 -1.01%
August 2025 44.88 43.12 -3.92%
September 2025 43.56 45.54 4.55%
October 2025 45.08 45.45 0.82%
November 2025 45.9 46.92 2.22%
December 2025 46.06 48 4.21%

Aclaris Therapeutics Stock Forecast for 2026

January 2026 47.04 51 8.42%
February 2026 49.98 50.96 1.96%
March 2026 50.96 53 4%
April 2026 51.94 54 3.97%
May 2026 55.08 52.47 -4.74%
June 2026 52.47 53.46 1.89%
July 2026 53.46 54.54 2.02%
August 2026 53.46 55.08 3.03%
September 2026 55.08 54.88 -0.36%
October 2026 57.12 54.45 -4.67%
November 2026 54.45 58.14 6.78%
December 2026 57.57 58.58 1.75%

Aclaris Therapeutics Stock Forecast for 2027

January 2027 56.84 58.41 2.76%